Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically … – GlobeNewswire (press release)
Finance News Daily |
Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically …
GlobeNewswire (press release) PLYMOUTH MEETING, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) — Inovio Pharmaceuticals, Inc. (NASDAQ:INO) demonstrated the synergistic effect of combining Inovio's TERT (telomerase reverse transcriptase) cancer immunotherapy in combination with a … How Many Inovio Pharmaceuticals Inc (NASDAQ:INO)'s Analysts Are Bearish? |
